Stock Ratings / Financials / CNS / options

LAZ (62) FHI (73) AAMI (52) HTGC (41) ⌘ Pro Terminal →

Cohen & Steers Inc (CNS) Options Positioning, Max Pain & Unusual Sweeps

$72.91 +4.08% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $73.31

Cohen & Steers Inc (CNS) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D • SELL / AVOID Cap $3.75B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $73.30 (+0.54%)🧬 Dilution Drag (+1.36% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.6% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-4.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CNS)Realized 20D OHLCV Swing Band: ±7%

Deterministic 5-Pillar Attribution (48/100 Composite)

🔍 WHY CNS SCORES 48/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+11/20 pts (23% of score)

20D Institutional Volume Accumulation (±7% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+11/20 pts (23% of score)

FRED Regime × Technicals: 52% of 52W Range • RSI-14 at 52.1 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution7/20 pts (-13 pt drag)

Dilution Drag (+1.36% YoY Shares) & executive Form 4 sales trim 13 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$69.26+0.5% Next Q

Q2 (-2Q)

Grade D$69.63+2% Next Q

Q3 (-1Q)

Grade D$71.00+2.7% Next Q

Current

Grade D$72.91-5.6% Hist 90D α

Trajectory: D (40) → D (48)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a CNS Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While CNS currently carries a cautious 48/100 (D) rating due to Insider Conviction & Share Dilution (7/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($74.24) and Max Pain ($76.56) forces dealer call-delta covering toward $90.89.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.36% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CNS• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “CNS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 48%NO 52%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±7%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (CNS)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for CNS.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CNS)

✓Walkthrough of CNS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CNS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +3.73%📐 HORIZONTAL RANGE

2026-10-30O $73.32H $73.49L $72.18C $72.91VOL 263.8K

RES: $84.85SUP: $63.80SMA50: $74.24SMA200: $72.02

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CNS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CNS Butterfly Map → + Track CNS →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

18.2%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CNS today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CNS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CNS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CNS)

Financials Rank #887 of 1096 ⚔️ LAZ vs CNS Full Matrix →

1. Head-to-Head Financials Peer Comparison (CNS vs. LAZ, FHI, AAMI, HTGC)

Industry: Investment Managers (79 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, Cohen & Steers Inc (CNS) ranks #887 by composite RQD confidence (48/100, grade D) and #319 by equity capitalization ($3.75B). Within this direct 5-issuer industry benchmark cohort, HTGC leads on earnings valuation at 9.3x trailing P/E, while AAMI leads on capital efficiency and profitability with 40.3% ROIC and — gross margin. FHI currently holds the highest overall quantitative score in the immediate peer group at 73/100 (B) compared with CNS at 48/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CNS ACTIVE Cohen & Steers Inc	D	48/100	24.5x	—	33.7%	+4.08%	$3.75B	Benchmark Subject
LAZ Lazard Inc.	C	62/100	16.3x	—	24.4%	+2.78%	$3.86B	/laz-vs-cns →
FHI Federated Hermes Inc.	B	73/100	10.7x	—	39.8%	+2.17%	$4.33B	/fhi-vs-cns →
AAMI Acadian Asset Management Inc.	D+	52/100	40.5x	—	40.3%	+0.06%	$3.24B	/aami-vs-cns →
HTGC Hercules Capital Inc.	D-	41/100	9.3x	—	15.3%	+1.75%	$3.16B	/htgc-vs-cns →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001284812

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Cohen & Steers Inc (CNS) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of $153.2M, operating cash flow of -$120.4M, and free cash flow of -$126.4M (-248.7% YoY). On the balance sheet, CNS closed FY2025 with $876.7M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$0	$153.2M	-$120.4M	-$126.4M	$876.7M	—
FY2024 (FY)	2024-12-31	$0	$151.3M	$96.7M	$85.0M	$812.4M	—
FY2023 (FY)	2023-12-31	$0	$129.0M	$172.0M	$172.0M	—	—

3. CNS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CNS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Cohen & Steers Inc (NYSE: CNS) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $72.91 (+4.08% 1D, market cap $3.75B). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 7/20. Across 1096 tracked Financials issuers, CNS ranks #887 in composite RQD confidence.

How does CNS compare to LAZ and FHI in the Financials sector?

Within the Financials sector (Investment Managers), CNS carries a Roarable D (48/100 RQD), trailing P/E of 24.5x, gross margin of —, and ROIC of 33.7%. By comparison, LAZ (Lazard Inc.) holds a C grade (62/100 RQD, P/E 16.3x, ROIC 24.4%, cap $3.86B) and FHI (Federated Hermes Inc.) posts a B grade (73/100 RQD, P/E 10.7x, ROIC 39.8%, cap $4.33B). Among the 5-stock peer group, HTGC leads on earnings multiple (9.3x) while AAMI leads on capital efficiency (40.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CNS?

Per CNS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001284812), Cohen & Steers Inc generated $0 in revenue, $153.2M in net income, and -$126.4M in free cash flow against $876.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CNS trading relative to its 50-day, 200-day, and 52-week technical levels?

CNS last traded at $72.91 (+4.08% on volume of 181,177 shares), positioning the stock -1.79% below its 50-day simple moving average ($74.24) and +1.24% above its 200-day simple moving average ($72.02). Across its 52-week range of $58.39 to $86.56, CNS sits at the 51.5% percentile with a 14-day RSI of 52.1 (NEUTRAL RANGE) and an implied next-earnings move of ±7.0% ($67.81 to $78.01).

CNS Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is CNS's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for CNS.

Direct Sub-Reports: CNS RQD Cockpit CNS 12M Forecast CNS Earnings & Move CNS Dividends & DRIP CNS Insiders & 13F CNS Whale Options CNS Profit Sankey CNS News & Why